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Abstract 
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a widespread environmental contaminant 
that causes altered heart morphology, circulatory impairment, edema, hemorrhage, and early life 
stage mortality in fish.  TCDD toxicity is largely dependent upon the aryl hydrocarbon receptor, 
but understanding of the molecular mechanism of cardiovascular embryotoxicity remains 
incomplete.  In order to identify genes potentially involved in cardiovascular impacts, we 
constructed custom cDNA microarrays consisting of 4,896 zebrafish adult heart cDNA clones 
and over 200 genes with known developmental, toxicological, and housekeeping roles.  Gene 
expression profiles were obtained for 3-day old zebrafish following early embryonic exposure to 
either 0.5 or 5.0 nM TCDD.  516 clones were significantly differentially expressed (p-value < 
0.005) under at least one treatment condition; 123 high-priority clones were selected for further 
investigation.  CYP1A, CYP1B1, and other members of the AHR gene battery, were strongly 
and dose-dependently induced by TCDD.  Importantly, altered expression of cardiac sarcomere 
components, including cardiac troponin T2 and multiple myosin isoforms, was consistent with 
the hypothesis that TCDD causes dilated cardiomyopathy.  Observed increases in expression 
levels of mitochondrial energy transfer genes also may be related to cardiomyopathy.  Other 
TCDD-responsive genes included fatty acid and steroid metabolism enzymes, ribosomal and 
signal transduction proteins, and 18 ESTs with no known protein homologs.  As the first broad-
scale study of TCDD-modulated gene expression in a non-mammalian system, this work 
provides an important perspective on mechanisms of TCDD toxicity.
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Introduction 
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a widespread environmental contaminant 
and a potent disruptor of cardiovascular development in vertebrates.  Hallmarks of TCDD 
embryotoxicity in fish include reduced heart size, circulatory failure, pericardial and yolk sac 
edema, hemorrhage, and early life stage mortality (Belair et al., 2001; Henry et al., 1997; 
Hornung et al., 1999).  In zebrafish, weakened cardiac contraction can be observed shortly after 
hatching, followed by congestion and reduced perfusion of peripheral vascular beds, and finally, 
edema and hemorrhage (Belair et al., 2001; Dong et al., 2002; Henry et al., 1997; Teraoka et al., 
2002).  This progression is generally conserved across fish species (Hornung et al., 1999; Wisk 
and Cooper, 1990), and is reminiscent of congestive heart failure. 
In avian embryos, TCDD causes dilated cardiomyopathy by inhibiting cardiomyocyte 
proliferation during a period of significant ventricular muscle growth and rearrangement 
(Ivnitski et al., 2001; Sedmera et al., 2000).  Reduced cardiac efficiency leads to congestive heart 
failure with manifest edema and hemorrhage (Ivnitski et al., 2001; Walker and Catron, 2000).  
Cardiac remodeling processes in fish are variable and poorly understood, but cross-species 
similarity in the overt toxicity of TCDD implies a common molecular mechanism. 
TCDD toxicity is largely dependent on the aryl hydrocarbon receptor (AHR) (Fernandez-
Salguero et al., 1996; Lin et al., 2002; Peters et al., 1999; Staples et al., 1998; Teraoka et al., 
2003), a ligand-activated transcription factor with strong affinity for dioxins and related planar 
halogenated aromatic hydrocarbons.  Binding of TCDD by cytosolic AHR causes activation, 
nuclear translocation, and dimerization with aryl hydrocarbon receptor nuclear translocator 
(ARNT).  The AHR-ARNT complex acts via DNA sequence motifs, known variously as AHR-, 
dioxin-, or xenobiotic-response elements (AHRE, DRE or XRE), to modulate gene expression.  
Transcriptional regulation is thought to be the primary means by which AHR mediates dioxin 
toxicity, but the identity of toxicity-causing target genes remains uncertain. 
CYP1A induction is the most sensitive known response to AHR activation and may 
contribute to dioxin toxicity.  The timing, distribution, and dose-dependence of CYP1A 
expression are all strongly correlated with symptoms of embryotoxicity in fish (Cantrell et al., 
1998; Cantrell et al., 1996; Gannon et al., 2000; Guiney et al., 1997; Toomey et al., 2001).  
CYP1A could cause toxicity via aberrant reactive oxygen production in the presence of 
substrates that are tightly bound but poorly metabolized (Schlezinger et al., 2000; Schlezinger et 
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al., 1999).  The protective effects of antioxidants indicate that reactive oxygen species (ROS) are 
involved in TCDD embryotoxicity (Cantrell et al., 1996).  However, direct assessments of the 
role of CYP1A in embryotoxicity have yielded conflicting results (Carney et al., 2004; Teraoka 
et al., 2003). 
AHR is capable of regulating expression of numerous other genes that could play important 
roles in embryotoxicity.  Microarray-based gene expression profiling and serial analysis of gene 
expression (SAGE) have provided a list of several hundred TCDD-responsive candidate genes in 
mammals.  Most of this work has focused on liver tissue and cultured hepatocytes (Frueh et al., 
2001; Kurachi et al., 2002; Puga et al., 2000; Zeytun et al., 2002), but spleen and thymus tissues 
(Zeytun et al., 2002), vascular smooth muscle cells (Guo et al., 2004; Karyala et al., 2004) and 
lung epithelial cells (Martinez et al., 2002) have also been interrogated.  While some general 
trends are emerging from these studies, substantial disparities emphasize the importance of dose, 
tissue-type, and likely numerous other biological factors in shaping molecular responses to 
TCDD.  Thus, it is difficult to gauge the relevance of available data to the specific problem of 
cardiovascular embryotoxicity. 
 The goal of the current work was to use cDNA microarrays to identify TCDD-responsive 
genes involved in developmental toxicity.  Expression profiling of 3-day old zebrafish following 
early embryonic exposure to two doses of TCDD revealed changes consistent with 
cardiomyopathy, including suppression of cardiac troponin T2 and induction of cardiac myosin 
isoforms.  Other changes in gene expression suggest subtle modulations in basal cellular 
functions, including mitochondrial energy transfer, fatty acid and steroid metabolism, signal 
transduction, and ribosomal machinery. 
 
Methods 
Chemicals 
2,3,7,8-tetrachloro[6-3H]dibenzo-p-dioxin (ChemSyn Laboratories) 2,3,7,8-
tetrachlorodibenzo-p-dioxin (ChemService) and  were obtained from providers in toluene 
solutions.  3H-TCDD alone or a 1:1 mixture of tritiated and unlabeled TCDD was dried and 
dissolved in DMSO at least 24 hrs prior to use. 
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Experimental Design 
Zebrafish embryos (strain TL) were exposed to 0.05% (vol/vol) DMSO or appropriate 
TCDD/DMSO solution in E3 egg water (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and 0.33 
mM MgSO4)for 1.5 hrs beginning at approximately the 1000-cell stage.  Embryos were then 
rinsed thoroughly and maintained in clean E3 egg water at 28°C.  Approximately 24 hrs after 
dosing, triplicate samples of 3 embryos per treatment group were dissolved in Solvable reagent 
(Packard).  Samples were mixed with Scintiverse II scintillation fluid (Packard) and dark-
adapted prior to liquid scintillation counting.  At 72 hours post fertilization (hpf), 50-100 larvae 
per treatment group were collected for RNA preparation.  Samples were either flash-frozen and 
stored at -80°C or transferred to RNALater (Ambion) and stored at -20°C. 
Samples for microarray analysis were obtained from two separate experiments.  In the 0.5 
nM TCDD experiment, control and treatment groups of ~100 embryos each were drawn from a 
single pool of embryos from multiple mating pairs.  Triplicate hybridizations were performed 
using three distinct DMSO-TCDD sample pairs (i.e. biological replication only).  In the 5.0 nM 
TCDD experiment, treatment groups of ~100 embryos were taken from individual matings; ~400 
embryos pooled from the same clutches comprised a control group.  Six hybridizations with 
cDNA from four treatment groups provided both biological and technical replication.  Due to 
differences in sampling design, data from the two experiments were not subjected to direct 
statistical comparisons. 
The sampling design for morphological and RT-PCR dose-response assessments was similar 
to that for the low-dose microarray experiment.  Replicate experiments were performed using 
distinct pools of embryos that were split into treatment groups of 100-200 embryos each. 
cDNA Microarrays 
A cDNA library made from zebrafish adult heart tissue was a kind gift of Dr. Ashok 
Srinivasan.  cDNA probes were generated by PCR amplification from bacterial lysates or 
plasmid DNA preparations using standard SP6, T3, and T7 primers.  Amplification success was 
monitored by gel electrophoresis of 12 reactions per 96-well plate.  PCR products were filter 
purified (Millipore Multiscreen-96 PCR Purification Plates), dried by vacuum centrifugation, and 
reconstituted in 25 µl 3x SSC + 0.1% Sarkosyl.  cDNA probes were arrayed onto Corning CMT-
GAPS slides using a GMS 417 Arrayer (Genetic Microsystems) equipped with four standard 
pins set to 250 µm center-to-center feature spacing.  Printed cDNAs were immobilized by UV 
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cross-linking (Stratalinker® UV Crosslinker, Stratagene).  Arrays were washed 2 min each in 
95°C nuclease-free water and 95% ethanol, air-dried, and stored in a light-protected dessication 
chamber.  Array quality was assessed using homotypic hybridizations, performed according to 
the protocol below with aliquots of a single adult zebrafish heart RNA preparation.  
Microarray Hybridization 
Total RNA was isolated from whole embryos using TriZol reagent (Invitrogen).  Amino-allyl 
modified cDNA was generated by reverse transcription in the presence of amino-allyl-dUTP.  
Total RNA (15−25 µg) spiked with A. thaliana chloroplast mRNA (100, 250, and 500 ng of Cab, 
RCA, and rbcL RNA, respectively; SpotReport®-3 Array Validation Kit, Stratagene) was 
incubated with 5 µg oligo-dT(20)N anchored primer for 10 min at 65°C, then chilled on wet ice.  
5x First-strand buffer (4 µl)and 0.1mM DTT (2 µl) were added for a final reaction volume of 20 
µl.  Remaining reagents were then added for final reaction conditions of 1x first-strand synthesis 
buffer, 10mM DTT, 0.5mM each dATP, dCTP and dGTP, 0.3mM dTTP, 0.2mM amino-allyl-
dUTP, and 1000U Superscript II reverse transcriptase.  Reverse transcription reactions were run 
2.5 hrs at 42°C, then inactivated by buffering with 0.5M EDTA and incubating 5 min at 95°C.   
RNA was eliminated by alkaline hydrolysis in 0.2N NaOH and RNase digestion (Ambion 
RNase cocktail).  cDNA purification and buffer exchange was accomplished by filter-
purification according to standard protocols (QiaQuick PCR Purification Kit, Qiagen), except 
that Qiagen buffers PE and EB were replaced by 75% ethanol and distilled water, respectively.  
cDNAs were dried by vacuum centrifugation and stored at -20°C. 
For CyDye post-labeling, cDNAs were redissolved in 10 µl 0.1M NaHCO3 (pH9.0) 
containing amine-reactive Cy3 or Cy5 (Amersham Biosciences), then incubated 1.5-2 hrs at 
room temperature in darkness.  The labeling reaction was quenched by 15 min incubation with 
excess hydroxylamine.  Following addition of 35 µl 100mM NaOAc  (pH 5.2) and 50 µl 
nuclease-free water, labeled cDNA was purified using QiaQuick PCR Purification columns 
(Qiagen) according to standard protocols.  cDNA concentrations were determined 
spectrophotometrically (A260, A280), then equal quantities of paired Cy3- and Cy5-labeled 
cDNAs were combined and dried by vacuum centrifugation. 
Immediately prior to hybridization, labeled target cDNA was dissolved in 3x SSC with 0.1% 
SDS, 0.4 µg/µl poly-A blocker (Sigma), 0.4 µg/µl yeast tRNA (Invitrogen), and 0.8 µg/µl 
sonicated salmon sperm DNA (Fisher Scientific), then denatured 2 min at 95°C.  Overnight 
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hybridizations were performed at 65°C in sealed hybridization chambers containing a reservoir of 
2x SSC.  Hybridized arrays were washed 3-5 min each with 2x SSC + 0.1% SDS, 1x SSC, and 
0.1x SSC, then dipped briefly into distilled water and isopropanol, and air-dried.   
Microarray Data Analysis 
Array image capture and analysis was performed using an Axon 4000A scanner (10 µm 
resolution) equipped with GenePix 3.0 software.  GenePix results files were deposited into the 
Rosetta Resolver Enterprise Gene Expression Data Analysis System (Rosetta Biosoftware, 
Kirkland, WA).  Rosetta Resolver generates background-subtracted ratio data by applying a 
platform-specific error model to mean fluorescence intensities and standard deviations calculated 
by GenePix.  Intra-array normalization is performed according to a piece-wise linear function 
that fits and corrects for intensity non-linearity; this method is a modification of that proposed by 
Schadt and colleagues (Schadt et al., 2002).  Data from replicate hybridizations are combined to 
obtain error-weighted mean ratio data for each treatment group; the contribution of individual 
data points to the mean is determined by the calculated measurement error.  Features with 
log(intensity) < -2.0 were excluded from analyses, and features with p-value < 0.005 for the 
group mean ratio were considered differentially expressed.   
Real-time RT-PCR 
Total RNA was prepared using TriZol reagent (Invitrogen), then treated with DNase I 
(Ambion DNA-free™).  cDNA was generated by oligo-dT-primed reverse transcription of 2 µg 
total RNA with Superscript II RT (Invitrogen).  Reactions containing all materials except reverse 
transcriptase (RT- controls) served as controls for genomic DNA contamination.  Real-time PCR 
reactions consisting of 1x SYBR® Green PCR Master Mix (Applied Biosystems), 1 µl cDNA 
(or RT- control reactions), and 400 nM each primer, were subjected to instrument default cycling 
parameters, including dissociation curve analysis (ABI Prism 7000).  Threshold-crossing cycle 
numbers (Ct) were determined at background-subtracted fluorescence r=0.2, and relative 
expression ratios (R) were calculated according to the previously described (Pfaffl, 2001) 
equation:  
 
 
R =
(Etarget)
ΔCttarget(DMSO – TCDD)
(Eref)
ΔCtref(DMSO – TCDD)
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where β-actin was the reference gene, and amplification efficiencies (E) were determined as the 
slope of the log-linear regression of fluorescence data from the exponential phase of 
amplification (LinRegPCR, Ramakers et al., 2003).  Mean E values were calculated for each 
technical replicate and used to calculate ratios for each sample in that group.  RT- control 
reactions did not produce significant amplification signal within the range of cycle numbers used 
for relative quantitation, and thus, were not included in calculations of relative expression levels. 
 
Results 
Cardiovascular cDNA microarrays 
Zebrafish cardiovascular cDNA microarrays consisted of 5,184 cDNA probes (see 
supplemental data for complete probe list and microarray data) immobilized on glass slides.  The 
vast majority of probes (4,896) were amplified from arbitrarily selected, uncharacterized adult 
heart cDNA clones.  The originating adult heart cDNA library was comprised of approximately 
65% unique clones and 35% redundant copies of high abundance transcripts (based on 
sequencing of 200 randomly selected clones, data not shown).  Thus, the arrayed probes likely 
represent approximately 2,800 unique genes.  These were supplemented with probes for genes of 
known developmental (e.g. Nkx2-5, GATA family members) or toxicological (e.g. AHR, 
CYP1A) relevance, constantly expressed housekeeping genes (e.g. β-actin), and exogenous 
hybridization controls (SpotReport™-3 cDNA Array Validation System, Stratagene).   
Homotypic control hybridizations using total RNA from adult heart tissue revealed consistent 
feature morphology, strong signal:noise ratios, and minimal systematic bias.  In a typical 
example, the mean feature diameter was 190.88±23.36 µm and features with abnormal (i.e. non-
round) morphology were rare.  The median signal:noise ratios for Cy3 and Cy5 channels were 
12:1 and 9:1, respectively.  The best-fit line for the fluorescence intensity scatter plot had an 
unadjusted slope of 1.19 (Figure 1, R2 = 0.91) and the 99.7% confidence interval (3 standard 
deviations from the population mean) of median-centered data fell at a Cy3:Cy5 ratio of ±1.78. 
Experimental design 
Gene expression profiles were obtained from 72 hpf embryos exposed to either 0.5 nM 
TCDD (1.84±0.42 ng TCDD/g embryo, n = 3 treatment groups) or 5.0 nM TCDD (10.74±1.38 
ng TCDD/g embryo, n = 4 treatment groups) at the 1000-cell stage.  In the 0.5 nM TCDD group, 
there was a slight increase in the occurrence of mild pericardial edema and most embryos 
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showed modest reductions in the rate of blood flow in the tail (Figure 2).  In contrast, exposure to 
5.0 nM TCDD produced maximal responses, including severe edema and severe to complete 
circulatory failure in 100% of assayed embryos.  However, neither dose caused a significant 
increase in mortality through 96 hpf.  These two concentrations represented the extremes of the 
dose-response curves, which were similar to those observed in other zebrafish strains (Henry et 
al., 1997). 
All microarray control features demonstrated the expected responses (or lack thereof) to 
TCDD exposure (Table 1).  Arabidopsis thaliana mRNAs spiked into experimental samples at 
equimolar concentrations showed no significant deviations from 1:1 ratios.  Known 
housekeeping genes (i.e. β-actin and ARNT2) also were unaffected by TCDD exposure.  In 
contrast, CYP1A was strongly and dose-dependently induced by TCDD.  AHR2 showed a subtle 
but highly significant induction similar to that previously observed (Andreasen et al., 2002).   
Real-time RT-PCR measurements of control genes were generally consistent with microarray 
results.  Prior to normalization, RT-PCR data indicated no significant change in expression of 
ARNT2, but showed a significant trend toward down-regulation of β-actin (Figure 3a, single-
factor ANOVA p-value < 0.05).  A similar downward trend was seen in many of the genes 
assayed, including those expected to be up-regulated, suggesting that this trend was artifactual.  
Thus, RT-PCR data were normalized to β-actin.  Both β-actin-normalized and raw RT-PCR data 
indicated strong induction of CYP1A at 0.5-15 nM TCDD (Figure 3b, single-factor ANOVA p-
value < 0.005).  However, the magnitude of induction varied markedly between biological 
replicates and did not follow the expected dose-response curve (Figure 3b).  
TCDD-modulated gene expression 
 516 clones were significantly differentially expressed (p-value < 0.005) at one or both TCDD 
concentrations.  Overall, changes in expression levels were relatively subtle, with the median 
magnitude of change falling between 1.30 and 1.35 for both doses.  Less than 10% of 
differentially expressed clones showed significant changes at both doses, and 131 clones were 
differentially expressed only at the lower dose.  The total number of differentially expressed 
clones was greater at 5.0 nM TCDD (385 vs. 182), but this may be attributable, in part, to 
differences in statistical power.  High-dose mean data were based on 4 biological and 2 technical 
replicates, while 3 biological replicates were used in the low-dose experiment.  Analyses based 
on any subset of three high-dose biological replicates resulted in numbers of significant changes 
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similar to those observed for the low dose.  Thus, direct statistical comparisons between doses 
were avoided so as to not introduce sampling artifacts. 
At this level of statistical confidence, the expected false discovery rate was 52 clones, 
approximately 10% of all detected changes.  To limit the number of false positives passed to 
further investigation, 123 high-priority clones were selected using three additional criteria:  
1) P-value <0.005 at BOTH doses (51 clones),  
2) P-value <0.005 AND absolute fold change ≥1.8 (99.7% C.I.) at either dose (65 clones), or 
3) Concordant evidence from redundant probes (12 genes, 2 ESTs), as determined from first-
pass sequencing of  approximately 300 clones with p-values < 0.005.  These redundant 
clones comprised nearly one third of all clones sequenced. 
Ultimately, high-quality sequence data was obtained for 119 of 123 high-priority clones.  
Translated BLAST searches against public databases identified 42 known genes (Table 2) and 18 
ESTs with no known homologs (Table 3).  Known genes were classified into five broad 
functional groups, discussed below. 
 This subset of genes/ESTs reflected general trends seen in the larger dataset.  The number of 
high-priority differentially expressed genes was slightly greater at 5.0 nM TCDD (56 vs. 49 
genes/ESTs), but the average magnitude of change was not significantly different (2.54±0.87 vs. 
2.76±1.09).  Up-regulated genes/ESTs far outnumbered those down-regulated; only 11 genes, 4 
ESTs, and 4 unidentified clones were suppressed by TCDD. 
Metabolic genes 
 TCDD exposure resulted in differential expression of genes involved in multiple metabolic 
pathways, most notably xenobiotic metabolism (Table 2a).  CYP1A, CYP1B, and glutathione S 
transferase π, all members of the mammalian AHR gene battery, were dose-dependently induced.  
Major vault protein, a membrane channel involved in multi-drug resistance, was also induced.  
Pyrimidine 5’ nucleotidase and the steroid biosynthesis enzyme 20 β-hydroxysteroid 
dehydrogenase also were dose-dependently induced. 
 Effects on fatty acid regulators were mixed.  Acyl-coA dehydrogenase and TP-β showed 
signs of subtle induction by TCDD.  In contrast, expression of liver-basic fatty acid binding 
protein (LB-FABP) was dose-dependently suppressed. 
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Cardiovascular genes 
 Genes encoding components of cardiac muscle sarcomeres showed mixed responses to 
TCDD exposure (Table 2b).  Cardiac α-actin showed signs of slight suppression, but this effect 
could not be confirmed by RT-PCR (data not shown).  In contrast, expression of several cardiac 
myosin isoforms, not all of which could be definitively identified, appeared to be induced.  In 
both cases, these effects were most pronounced at 0.5 nM TCDD.  However, as previously noted, 
direct statistical comparison between doses was not performed because of possible differences in 
statistical power. 
 Cardiac troponin T2 (tnnt2) probes provided conflicting data. Multiple clones indicated 
significant induction of tnnt2 at both dose levels, while a single clone suggested dose-dependent 
suppression of tnnt2 expression.  Real-time RT-PCR confirmed the latter result, indicating ≤1.8-
fold suppression of cardiac troponin T2 (Figure 4a, single-factor ANOVA p-value < 0.01).  To 
address the possibility of cross-hybridization artifacts, expression of three additional troponin 
isoforms was assayed by RT-PCR.  Skeletal slow muscle troponin T showed a trend toward 
slight suppression (Figure 4a, single-factor ANOVA p-value > 0.05), while skeletal fast muscle 
troponin T was significantly induced (Figure 4a, single-factor ANOVA p-value < 0.01).  Skeletal 
troponin C levels were unaffected (not shown). 
Mitochondrial genes 
 Highly redundant probe sets suggested subtle induction of several protein-coding 
mitochondrial genes, including cytochrome b (cytb), cytochrome c oxidase (CCO), and NADH 
dehydrogenase (ND) (Table 2c).  We attempted to verify suggested alterations in cytb, CCO 
subunit I, and ND subunit 2 expression using real-time RT-PCR.  Results from one biological 
replicate were consistent with 1.2-1.5-fold induction of all three genes by TCDD, but the second 
biological replicate showed no significant increase in expression levels.  Overall, variability 
between replicate samples obscured any statistical significance (Figure 4b, ANOVA p-value > 
0.05). 
 Three cDNA clones matched ATP synthase sequences in public databases.  One was 
identified as mitochondrial ATP synthase 6 by alignment with the zebrafish mitochondrial 
genome sequence.  This probe indicated slight upregulation, similar to other mitochondrial 
genes.  RT-PCR measurements failed to confirm any significant induction of mitochondrial ATP 
synthase 6 (single-factor ANOVA p-value > 0.05, data not shown).  Limited sequence data 
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precluded definitive identification of the remaining two clones, one of which indicated 
suppression, the other slight induction. 
Ribosomal genes 
 Genes encoding both RNA and protein components of the ribosomal machinery tended to be 
down-regulated by TCDD exposure (Table 2d).  RT-PCR failed to detect significant differences 
in rRNA expression levels (not shown).  RT-PCR verification of changes in levels of transcripts 
encoding ribosomal proteins was not attempted. 
Miscellaneous 
 Eight additional TCDD-responsive genes either could not be classified or were the sole 
representative of a functional category (Table 2e).  Two calcium-transporting ATPases were up-
regulated by TCDD.  Small membrane protein 1, protein kinase C inhibitor protein 1, annexin 
XIa, and cryptochrome 1a were all significantly induced by both concentrations of TCDD.  β-
spectrin and chaperonin containing t-complex protein 1 were both induced by 0.5 nM TCDD. 
 
Discussion 
 We have generated cDNA microarrays representing approximately 2,800 zebrafish genes.  
We used these arrays to identify 516 cDNAs that were differentially expressed in 3 day old 
zebrafish following early embryonic exposure to approximate cardiovascular ED10 and ED100 
concentrations of TCDD.  A subset of high-priority cDNAs chosen for further investigation 
consisted of 42 known genes and 18 ESTs. 
Dose level was a primary factor determining transcriptional responses to TCDD exposure.  
Less then ten percent of all differentially expressed clones met statistical significance criteria at 
both doses, and many genes were differentially expressed only at the lower dose.  Likewise, 
Martinez and colleagues (Martinez et al., 2002) found that more than half of all TCDD-regulated 
genes were differentially expressed at only one of three doses.  Genes that are responsive to 
TCDD over a large range of exposure levels may be of interest as biomarkers; certainly, this has 
been the case for CYP1A.  The remaining genes highlight the diversity of TCDD dose-response 
relationships and the importance of considering low-dose adaptive responses as distinct from 
toxicity-related changes apparent at higher doses.    
 Only two genes – CYP1A and CYP1B1 – were induced >4-fold.  CYP1A induction is a 
universal, sensitive response to TCDD exposure in vertebrates, and CYP1B1 induction by TCDD 
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has been observed in several systems (Tang et al., 1996; Walker et al., 1999).  However, these 
genes are not expressed in normal zebrafish embryos (Andreasen et al., 2002; Yamazaki et al., 
2002), suggesting that ectopic induction of genes that are normally “turned off” may be a more 
important mechanism of action for TCDD than is modulation of normal cardiovascular 
programs.  Such effects would be largely missed using the current microarray platform, as it is 
built from cDNAs expressed in normal adult heart tissue.   
Subtle modulation of constitutively expressed genes is interesting in itself.  Widespread, 
subtle changes in gene expression, as opposed to strong pressure on specific pathways, have been 
noted in other TCDD gene expression profiling experiments (Frueh et al., 2001; Puga et al., 
2000).  Signal compression does not completely explain this trend, since microarray 
measurements of CYP1A and AHR2 induction were similar to both current and previously 
published RT-PCR data (Andreasen et al., 2002).  Additionally, Martinez and coworkers 
(Martinez et al., 2002) confirmed the magnitude of several subtle TCDD-induced changes 
detected by microarray.  Thus, gene expression profiling is reaffirming the pleiotropic nature of 
impacts by TCDD, as well as the unique sensitivity of the CYP1 family to regulation by TCDD. 
While the biological importance of low-magnitude changes in gene expression remains an 
open question, there is growing recognition that subtle modulation of multiple members of a 
single pathway can be physiologically relevant.  This idea has driven the recent development of 
microarray analysis techniques, such as Gene-Set Enrichment Analysis (Mootha et al., 2003), 
designed to detect changes that are not statistically significant at the level of a single gene but 
become significant when functional groups are considered as an entity.  A posteriori 
identification of differentially expressed cDNAs makes the current data unsuitable for such 
analyses.  However, sarcomeric components and mitochondrial energy transfer genes seem to be 
compelling examples of over-represented functional groups. 
The current data reflect whole-organism average responses that could result from more 
dramatic effects in specific tissues.  For example, the heart makes up less than 2% of the total 
body mass of a 3-day old zebrafish.  A ten-fold change in cardiac expression of a gene that is 
highly expressed throughout the embryo would produce less than a 20% change in overall 
expression level.  Unfortunately, high background expression precludes reliable detection of 
tissue-specific changes using in situ methods, and larval zebrafish organs are prohibitively small 
for individual analysis. 
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TCDD-induced cardiomyopathy 
Observed differential expression of sarcomeric genes lends weight to the idea that developing 
fish suffer the same cardiac pathology as TCDD-exposed chicken embryos, namely dilated 
cardiomyopathy.  Increased myosin expression is apparent in both cases (Walker and Catron, 
2000).  The significance of this elevation is uncertain, but the observation is not unprecendented; 
induction of sarcomeric genes, including troponins and myosins, has been documented in human 
cardiomyopathies (Barrans et al., 2002; Haase et al., 2002; Hwang et al., 2002).  Observed 
reductions in troponin T2 transcript levels are consistent with dilated myopathy, and could be 
causally related to toxicity, just as loss-of-function mutations in human homologs are the leading 
causes of congenital cardiomyopathies (Seidman and Seidman, 2001).  Thus, the current results 
are in accord with data from congenital and TCDD-induced cardiomyopathy in other species. 
Discrepancies between microarray and RT-PCR data for cardiac tnnt2 do not interfere with 
this conclusion.  The disparity may be explained either by cross-hybridization of microarray 
probes with other troponin T isoforms or by sequence-specific dye incorporation artifacts that are 
relatively common in microarray experiments without dye swapping.  While all cDNA probes 
derived from the same region of the tnnt2 gene, slight differences in the 5’ extent of the cDNA 
may have contributed to different hybridization affinities or dye bias.  Control hybridizations had 
indicated minimal dye bias, so limited sample RNA was conserved by eliminating dye swapping.  
RT-PCR, which is not subject to such sequence-dependent artifacts, provides robust evidence for 
differential expression of cardiac and skeletal muscle troponin T isoforms. 
Reduced cardiac size in TCDD-exposed fish seems contradictory to cardiomyopathy, but 
may be explained by differences in hemodynamic forces.  Dilated cardiomyopathy typically 
results in increased ventricular diameter due to distension of the weakened muscle wall by fluid 
pressure.  In the case of fish, TCDD-induced congestion of peripheral vasculature and red blood 
cell loss may relieve such pressure.  The only obvious distending force is pericardial edema, 
which elongates the heart.  Thus, the disruption of cardiomyocyte proliferation that leads to 
dilated cardiomyopathy in chicken could produce an atypical myopathy with reduced cardiac 
size in fish.  
 A pressing question is the nature of the relationship between sarcomeric gene expression and 
cardiomyocyte proliferation or cardiomyopathy.  Uncoordinated expression of sarcomeric 
components could lead to sarcomere misassembly and weakened cardiac muscle.  Alternatively, 
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reduced troponin T levels could simply reflect a reduced number of troponin-expressing cells.  It 
is impossible to distinguish such possibilities with the data currently available.   
 Direct regulation of sarcomeric genes by AHR may be possible.  In silico searches suggest 
potential AHR binding sites upstream of mammalian myosins, tropomyosins, and inhibitory 
troponin (Fielden and Zacharewski, 2000), as well as zebrafish cardiac troponin T2 (Handley-
Goldstone, unpublished).  However, no functional data are available for these motifs.  It will be 
important to determine which factors regulate sarcomeric gene expression and what role(s) they 
play in toxicity.  
Mitochondrial gene expression and reactive oxygen 
The current data suggest modest induction of mitochondrial electron transport genes.  The 
failure of real-time RT-PCR to confirm the statistical significance of microarray results may be 
due to differences in experimental design.  Only two biological replicates were used for RT-
PCR, as compared to at least three in all microarray experiments.  Furthermore, the RT-PCR 
replicates showed obvious differences in response levels, with replicate #2 consistently 
demonstrating smaller magnitudes of change.  This was true for CYP1A and cardiac troponin T2, 
but the disparity did not impact the statistical significance of these larger changes to the same 
degree.  TCDD uptake was not monitored in RT-PCR experiments; variation in uptake efficiency 
may explain both the variability between biological replicates and the early plateau in dose-
response curves.  
In contrast, changes in levels of mitochondrial rRNAs indicated by microarray analyses may 
represent false positives.  Detection of rRNAs was unexpected, as these transcripts are not poly-
adenylated and cDNA synthesis for both microarray hybridization and PCR was oligo-dT 
primed.  In this case, RT-PCR failed to demonstrate even a trend consistent with the microarray 
data.  However, no RT-PCR data are available for ribosomal protein-encoding transcripts and 
this remains an interesting question relating to TCDD effects on mitochondrial function.  
Elevated levels of mitochondrial electron transport proteins could contribute to toxicity via 
reactive oxygen-mediated processes.  Both CYP1A(1) (Schlezinger et al., 2000; Schlezinger et 
al., 1999) and mitochondria have been identified as AHR-dependent sources of ROS (Senft et 
al., 2002a; Senft et al., 2002b).  Increased respiration-dependent reactive oxygen production by 
mitochondria has been observed in TCDD-treated mouse liver (Senft et al., 2002a; Senft et al., 
2002b).  In cardiac mitochondria, TCDD-induced ROS production has been linked to decoupling 
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of respiration and downstream oxidative phosphorylation processes (Nohl et al., 1989).  TCDD-
induced differential expression of mitochondrial and downstream energy transfer genes has been 
observed in this and other studies (Frueh et al., 2001; Kurachi et al., 2002), and suggests a 
mechanism for decoupling of mitochondrial electron transfer associated with ROS production. 
Mitochondrial ROS production might, in turn, be one pathway to cardiac toxicity.  Induction 
of mitochondrial electron transfer proteins, including NADH dehydrogenase, has been seen in 
human cardiomyopathies (Hwang et al., 2002).  Evidence of a causal link between excess ROS 
production and cardiac pathologies is increasing (Dhalla et al., 2000; Ide et al., 1999; Sorescu 
and Griendling, 2002). 
Conclusions 
As the first characterization of TCDD gene expression profiles in a non-mammalian system, 
this work provides a unique perspective and lends weight to emerging trends, particularly the 
plieotropic and dose-specific nature of transcriptional modulation by TCDD.  Furthermore, 
observed derangements in cardiac and mitochondrial gene expression provide evidence for 
cardiomyopathy in zebrafish and bring an enhanced degree of unity to ongoing studies of 
cardiovascular toxicity in fish and birds. 
Not surprisingly, though, this work has generated more intriguing questions than conclusive 
answers.  What, if any, are the physiological impacts of widespread, subtle changes in gene 
expression?  What roles do changes in sarcomeric and mitochondrial gene expression play in 
toxicity?  Perhaps most exciting of all, what can the 18 TCDD-responsive ESTs identified here 
reveal about previously unknown aspects of TCDD toxicity? 
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Supplementary Data 
 Results from Rosetta Resolver analyses are included in the MS Excel workbook file 
Handley-Goldstone_Resolver_results.xls.  Raw microarray data from GenePix results files are 
included in the Microsoft Excel workbook file Handley-Goldstone_GenePix_data.xls.  
Hybridization images may be obtained upon request. 
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FIGURE LEGENDS 
Figure 1.  Scatter plot of unadjusted median Cy3 and Cy5 feature intensities on a representative 
homotypic hybridization using zebrafish adult heart total RNA. 
 
Figure 2.  Dose-response curves for TCDD-induced pericardial edema (a) and peripheral 
circulatory impairment (b) in 80 hpf embryos.  Frequency (lines) of symptoms was determined 
from 100 randomly sampled embryos.  Mean severity scores (bars) were calculated from ranks 
assigned to individual embryos according to the following scheme: 0 = no adverse affect; 1 = 
mild edema, or slowed caudal blood flow; 2 = moderate edema, or reduced blood cell number 
and flow rate; and 3 = severe edema, or no visible peripheral circulation. 
 
Figure 3.  Real-time RT-PCR data for control genes.  a: mean expression ratios and standard 
errors for β-actin (circles) and ARNT (squares), as determined from two biological and two 
technical replicates.  b: CYP1A expression ratios from duplicate measurements of two biological 
replicates. 
 
Figure 4.  Mean expression ratios and standard errors for troponin isoforms (a) and 
mitochondrial genes (b), as determined from real-time RT-PCR data for two biological replicates 
and two technical replicates.  ctnnt2 = cardiac troponin T2; ss-tnnt = skeletal slow muscle 
troponin T; sf-tnnt = skeletal fast muscle troponin T; CCO1 = cytochrome C oxidase subunit 1; 
cytb = cytochrome b; ND2 = NADH dehydrogenase subunit 2. 
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Table 1.  Microarray data for exogenous and endogenous control probes.  A. thaliana mRNAs 
were added to experimental samples in equimolar amounts to produce 1:1 ratios.  Biological 
controls were unmanipulated. 
 
 0.5 nM TCDD 5.0 nM TCDD 
Gene Name Ratio P-value Ratio P-value 
  
A. thaliana spiked controls       
  chlorophyll a/b-binding protein (CAB)  1.18 0.377  -1.07 0.466 
  RUBISCO activase (RCA)  -1.29 0.287  -1.29 0.007 
  RUBISCO large subunit (rbcL)  1.34 0.264  -1.11 0.446 
       
Biological negative controls       
  β-actin  -1.02 0.971  -1.29 0.109 
  ARNT  1.26 0.345  1.23 0.263 
       
Biological positive controls       
  aryl hydrocarbon receptor 2 (AHR2)  1.85 0.000  1.93 0.000 
  cytochrome P450 1A (CYP1A)  44.02 0.000  62.78 0.000 
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Table 2.  Known genes whose expression is significantly modulated by TCDD.  ND = not 
detected; NC = no significant change (p-value > 0.005).  
 
 0.5 nM TCDD  5.0 nM TCDD
Gene Name # Probes Ratio P-value   Ratio P-value
        
(A) METABOLIC PROCESSES        
Xenobiotic metabolism        
  aryl hydrocarbon receptor 2 (AHR2) 4  1.85 0.000  2.32 0.000 
  cytochrome P450 1A (CYP1A) 1  44.02 0.000  62.78 0.000 
  cytochrome P450 1B1 (CYP1B1) 1  -- ND --  5.00 0.002 
  glutathione S transferase π (GSTπ) 1  -- NC --  1.91 0.000 
  major vault protein 1  1.54 0.002  1.85 0.000 
        
Fatty acid metabolism        
  liver-basic fatty acid binding protein 1  -- NC --  -1.87 0.003 
  acyl-coenzyme A dehydrogenase 1  1.35 0.000  1.34 0.000 
  trifunctional enzyme β subunit (TP-β) 1  1.28 0.000  1.37 0.000 
        
Steroid synthesis        
  20 β-hydroxysteroid dehydrogenase 1  -- NC --  2.35 0.000 
        
Pyrimidine metabolism        
  pyrimidine 5' nucleotidase, cytosolic III 1  -- NC --  1.89 0.000 
        
        
(B) SARCOMERE COMPONENTS        
cardiac alpha actin 4  -1.50 0.0002  -1.34 0.0000 
        
cardiac troponin T2 8  1.88 0.0000  1.66 0.0000 
cardiac troponin T2 1  -- NC --  -1.66 0.0000 
        
cardiac myosin light chain 1 1  1.31 0.0000  1.47 0.0005 
cardiac myosin light chain 2 3  1.83 0.0000  1.29 0.0005 
myosin light chain, similar to atrial 1  1.78 0.0036  -- NC -- 
        
cardiac beta-myosin heavy chain  1  1.41 0.0032  1.31 0.0000 
ventricular myosin heavy chain 2  1.77 0.0000  -- NC -- 
myosin heavy chain, similar to cardiac 1  2.14 0.0001  -- NC -- 
myosin heavy chain, similar to slow muscle 1  1.79 0.0002  -- NC -- 
        
        
(C) MITOCHONDRIAL ENERGY TRANSFER        
cytochrome b 3  1.30 0.0000  1.22 0.0000 
        
cytochrome c oxidase subunit I 8  1.38 0.0009  1.35 0.0000 
cytochrome c oxidase subunit III 1  1.96 0.0008  -- NC -- 
        
NADH dehydrogenase subunit 1 1  -- NC --  1.30 0.0000 
NADH dehydrogenase subunit 2 5  1.50 0.0000  1.34 0.0000 
NADH dehydrogenase subunit 4/4L 6  1.41 0.0000  1.27 0.0000 
NADH dehydrogenase subunit 5 2  1.44 0.0007  1.41 0.0000 
NADH dehydrogenase subunit 6 2  -- NC --  1.51 0.0000 
        
ATP synthase 1  -1.86 0.0000  -- NC -- 
ATP synthase 6 1  -- NC --  1.31 0.0000 
H+-transporting ATP synthase 1  1.20 0.0032  1.42 0.0000 
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(D) RIBOSOMAL MACHINERY        
mitochondrial 12s rRNA 2  -1.57 0.0002  -1.76 0.0000 
mitochondrial 16s rRNA 1  -- NC --  -2.11 0.0000 
        
60s ribosomal protein L39 1  -- NC --  -1.35 0.0001 
ribosomal protein L13A 1  -- NC --  -1.16 0.0000 
40s ribosomal protein S18 1  -1.84 0.0035  -- NC -- 
60s ribosomal protein 17a 1  -1.92 0.0014  -- NC -- 
        
        
(E) MISCELLANEOUS        
Ca2+ ATPase (SERCa) 1  -- NC --  1.24 0.0040 
Ca2+-transporting ATPase 1  1.55 0.0010  1.40 0.0005 
small membrane protein 1 1  1.29 0.0034  1.43 0.0000 
annexin XIa 1  1.40 0.0001  1.40 0.0006 
protein kinase c inhibitor protein 1 1  1.50 0.0006  1.27 0.0015 
cryptochrome 1a 1  1.81 0.0043  1.85 0.0000 
beta-spectrin (sptb) 1  1.83 0.0024  -- NC -- 
chaperonin containing t-complex protein 1 1  1.94 0.0000  -- NC -- 
 
 
 
Table 3.  ESTs without known homologs and unidentified sequences whose expression is 
modulated by TCDD.  ND = not detected; NC = no significant change (p-value > 0.005). 
 
    0.5 nM TCDD  5.0 nM TCDD 
Probe/Cluster ID # Probes   Ratio P-value   Ratio P-value 
        
(A) NO KNOWN HOMOLOGS       
TR001 2  1.97 0.0000  2.33 0.0000 
TR004 18  1.82 0.0000  2.12 0.0000 
        
AH045251 1  -- ND --  1.93 0.0002 
AH044370 1  -- ND --  2.05 0.0000 
AH045914 1  -- NC --  1.84 0.0001 
AH046765 1  -- NC --  1.83 0.0004 
AH045830 1  -- NC --  2.12 0.0000 
AH044267 1  -- NC --  2.29 0.0002 
AH045770 1  1.35 0.0016  1.17 0.0016 
AH046483 1  1.38 0.0006  1.29 0.0014 
AH046317 1  1.42 0.0006  1.53 0.0000 
AH046418 1  1.44 0.0035  1.37 0.0001 
AH042619 1  1.52 0.0001  2.21 0.0028 
AH045730 1  1.75 0.0030  1.24 0.0001 
AH042622 1  2.01 0.0017  -- ND -- 
        
AH042585 1  -1.45 0.0004  -1.58 0.0002 
AH040736 1  -1.51 0.0000  -1.22 0.0010 
AH039190 1  -1.84 0.0042  -1.51 0.0719 
uni2313 1  -2.87 0.0036  -- NC -- 
        
(B) LOW QUALITY SEQUENCE       
AH039140 1  -- NC --  -2.19 0.0029 
AH038856 1  -1.76 0.0033  -1.34 0.0050 
AH042259 1  -2.11 0.0059  -1.86 0.0000 
AH039112 1  -1.96 0.0039  -- NC -- 
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